A rating of 37 puts Evaxion Biotech A/S - ADR (EVAX) near the middle of the Biotechnology industry according to InvestorsObserver. Evaxion Biotech A/S - ADR's score of 37 means it scores higher than 37% of stocks in the industry. Evaxion Biotech A/S - ADR also received an overall rating of 40, putting it above 40% of all stocks. Biotechnology is ranked 29 out of the 148 industries.
EVAX has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on EVAX!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 40 would rank higher than 40 percent of all stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Evaxion Biotech A/S - ADR Stock Today?
Evaxion Biotech A/S - ADR (EVAX) stock is higher by 1.18% while the S&P 500 has fallen -0.01% as of 11:03 AM on Tuesday, Feb 6. EVAX has gained $0.05 from the previous closing price of $4.25 on volume of 35,539 shares. Over the past year the S&P 500 is higher by 20.22% while EVAX has fallen -76.11%. EVAX lost -$94.66 per share the over the last 12 months.
Click Here to get the full Stock Report for Evaxion Biotech A/S - ADR stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter